Target intelligence / Profile preview

Xenotropic and polytropic retrovirus receptor 1 (XPR1)

Target
XPR1
Molecular classification
Transporter, Solute carrier family 53, Phosphate exporter, Membrane protein, Retrovirus receptor
01

Overview

Xenotropic and polytropic retrovirus receptor 1 (XPR1) is a membrane transporter and the only known inorganic phosphate exporter in mammals, belonging to the solute carrier family 53 (SLC53A1)[1][3]. It has a dimeric structure with 10 transmembrane domains and a key cytoplasmic SPX domain involved in phosphate sensing and regulation[2][3]. XPR1 plays a central role in maintaining intracellular and systemic phosphate balance by exporting phosphate out of cells. It also serves as the cellular receptor for xenotropic and polytropic murine leukemia viruses, mediating their entry[1]. Pathogenic mutations in XPR1 can impair phosphate export, leading to diseases such as primary familial brain calcification (PFBC) characterized by ectopic brain calcifications and neurological symptoms[1][2]. There are currently no approved drugs targeting XPR1’s phosphate transport or viral receptor functions[2][3].

Other names
Solute carrier family 53 member 1SLC53A1SYG1X3X-receptorPhosphate exporter SLC53A1Protein SYG1 homologXenotropic and polytropic murine leukemia virus receptor X3IBGC6
02

Mechanism of action

Not applicable (no marketed drugs; potential future mechanisms may involve modulation or inhibition of phosphate export or viral entry[2][3].)

03

Biological functions

Inorganic phosphate exportMaintenance of phosphate homeostasisCell surface receptor for xenotropic and polytropic murine leukemia virusesRegulation by inositol polyphosphates
04

Disease associations

Neurodegenerative disease (e.g., primary familial brain calcification, PFBC)Potential role in infection (as viral entry receptor)
05

Safety considerations

Alteration or inhibition of XPR1 function risks disrupting phosphate homeostasis, potentially leading to toxic cytosolic phosphate accumulation and ectopic calcification (such as PFBC)[2][3].Any targeting therapy may risk neurological side effects due to the essential role of XPR1 in brain phosphate handling.
06

Biomarkers

Pathogenic XPR1 variants are used as molecular biomarkers for the diagnosis of primary familial brain calcification (PFBC)[1].

Beyond the preview

Go deeper on Xenotropic and polytropic retrovirus receptor 1 (XPR1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xenotropic and polytropic retrovirus receptor 1 (XPR1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call